Norges Bank Dyne Therapeutics, Inc. Transaction History

Norges Bank

$736 Billion
Q4 2024

A detailed history of Norges Bank transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Norges Bank holds 950,104 shares of DYN stock, worth $12.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

950,104

Holding current value

$12.5 Million

% of portfolio

0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$23.56 - $35.55 $22.4 Million - $33.8 Million	950,104 New	950,104 $22.4 Million
Q2 2024 Aug 14, 2024	BUY	$23.65 - $35.63 $2.53 Million - $3.82 Million	107,089 New	107,089 $3.78 Million
Q2 2023 Aug 14, 2024	BUY	$8.53 - $14.28 $754,998 - $1.26 Million	88,511 Added 82.65%	195,600 $2.2 Million
Q1 2023 May 15, 2024	BUY	$10.88 - $15.0 $3.96 Million - $5.45 Million	363,600 New	363,600 $4.19 Million
Q4 2022 Feb 14, 2023	BUY	$9.37 - $13.8 $1.48 Million - $2.18 Million	157,752 New	157,752 $1.83 Million
Q1 2022 May 12, 2023	BUY	$6.52 - $12.27 $2.88 Million - $5.43 Million	442,248 Added 280.34%	600,000 $5.78 Million
Q1 2022 May 09, 2022	SELL	$6.52 - $12.27 $4.59 Million - $8.63 Million	-703,400 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$11.89 - $16.07 $8.36 Million - $11.3 Million	703,400 New	703,400 $8.36 Million
Q3 2021 Nov 14, 2022	BUY	$15.6 - $21.46 $11.2 Million - $15.4 Million	717,100 New	717,100 $11.6 Million
Q3 2021 Nov 05, 2021	SELL	$15.6 - $21.46 $9.36 Million - $12.9 Million	-600,000 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$15.94 - $22.33 $9.56 Million - $13.4 Million	600,000 New	600,000 $12.6 Million
Q2 2021 Aug 10, 2021	SELL	$15.94 - $22.33 $9.56 Million - $13.4 Million	-600,000 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$14.0 - $29.3 $8.4 Million - $17.6 Million	600,000 New	600,000 $9.32 Million
Q1 2021 May 07, 2021	SELL	$14.0 - $29.3 $5.6 Million - $11.7 Million	-400,000 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$16.81 - $23.94 $6.72 Million - $9.58 Million	400,000 New	400,000 $8.4 Million
Q4 2020 Feb 10, 2021	SELL	$16.81 - $23.94 $8.08 Million - $11.5 Million	-480,769 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$20.0 - $23.9 $9.62 Million - $11.5 Million	480,769 New	480,769 $9.71 Million

Others Institutions Holding DYN

# of Institutions

213

Shares Held

103M

Call Options Held

135K

Put Options Held

435K

Atlas Venture Life Science Advisors, LLC

8.02M
Shares

$106 Million
31.16% of portfolio
Black Rock Inc. New York, NY

7.39M
Shares

$97.3 Million
0.01% of portfolio
Janus Henderson Group PLC London, X0

7.38M
Shares

$97.2 Million
0.09% of portfolio
Vanguard Group Inc Valley Forge, PA

6.7M
Shares

$88.3 Million
0.0% of portfolio
Ra Capital Management, L.P. Boston, MA

6.38M
Shares

$84 Million
2.43% of portfolio

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $682M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account